Status
Conditions
About
This is a longitudinal observational study, where we will track outcomes in patients undergoing 5 weeks of FDA approved right DLPFC rTMS treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Inclusion Criteria for healthy volunteers:
Exclusion Criteria for healthy volunteers:
54 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal